Another OTC drug of the NSAID group - Brustel was added to the Sun Pharma's portfolio in Russia.
The drug composition includes ketoprofen and is released in the form of a topical gel at a maximum therapeutic dosage of 5%.

Ketoprofen is one of the inhibitors of inflammatory mediators - cyclooxygenases. It also inhibits the lipoxygenase and bradykinin activity. It is able to stabilize lysosomal membranes and prevent the release of enzymes involved in the inflammatory process. The main properties of ketoprofen include a strong analgesic, anti-inflammatory and antipyretic effect. Ketoprofen has no adverse affect on the articular cartilage state. (1)

Thank to the double concentration of ketoprofen, “Brustel” achieves an analgesic effect in acute and chronic pain in the back, muscles and joints, relieves inflammation and swelling, and is also more economical (half the gel is required compared to Brustel 2.5 %). (2)

The drug is released in 50 g and 30 g tubes that allow both using it at home and keeping it in the first-aid kit.
Brustel is recommended for to reduce pain and inflammation in muscles and joints in osteoarthritis, myalgia, neuralgia, sciatica, injuries of the musculoskeletal system (including sports) and other inflammatory processes.*

The drug is manufactured by PJSC “Biosintez” (Penza).

 
1. Instruction leaflet for human use of medicinal product “Brustel”.
2. Compared to Brustel 2.5%, registration number: LS-002388 dated June 22, 2021.
 
* Information for specialists. The drug has contraindications. Check out the instructions.